top of page
Eyecelerator2025-1277.jpg

Eyecelerator @ AAO 2025

 

Register Now to Join Us on Oct. 16 | Orlando, FL

PROGRAM AGENDA
Registration + Networking Breakfast

7:00 – 8:00 a.m.

Registration and breakfast

​

Welcome Remarks

8:00 – 8:15 a.m.

Welcome and Overview of Eyecelerator @ AAO 2025​​​​

​

Speakers:

  • Stephen D. McLeod, MD, CEO, American Academy of Ophthalmology

  • Gil Kliman, MD, MBA, Program Director

  • Allen C. Ho, MD, Retina Program Director

S1: Do the Eyes Have It? Ophthalmic Commercial Dynamics and Investment Opportunities

8:15 – 9:00 a.m.

​​​Moderators:

  • Gil Kliman, MD, MBA, Program Director

  • Ramin Valian, VP, Eyecare Global Pipeline and Commercial Strategy, AbbVie

​

​Speakers: 

Market Overview

  • Kristen Harmon Ingenito, MBA, CEO, Market Scope

​

Capital Market Overview

  • Neha Begwani, MBA, Managing Director, Healthcare Investment,
    Morgan Stanley

​

VC Overview

  • Garrett Hamontree, MBA, Partner, Visionary Ventures

​

​Panel: 

  • Neha Begwani, MBA, Managing Director, Healthcare Investment,
    Morgan Stanley

  • Garrett Hamontree, MBA, Partner, Visionary Ventures

  • Kristen Harmon Ingenito, MBA, CEO, Market Scope

  • James C. Murray, JD, Founder and Managing Member, ExSight Ventures, LLC

  • Roger Zhang, PhD, VP, Samsara BioCapital

S2: Robotics in Ophthalmology: From Vision to Reality

9:00 – 9:45 a.m.

​​​Moderators: 

  • Reza Zadno, PhD, Former President & CEO, PROCEPT BioRobotics

  • Lejla Vajzovic, MD, Program Committee

​

Speaker: 

Medical Robotics

  • Frederic Moll, MD, MS, Co-Founder, Intuitive, Co-Founder & Partner, Sonder Capital


Panel: 

  • David F. Chang, MD, Chair, Clinical Advisory Board, ForSight Robotics

  • Jean-Pierre Hubschman, MD, Co-Founder and CEO, Horizon Surgical System

  • Franck Leveiller, PhD, SVP, Chief Scientific Officer and Senior Vice President, Head Global Research & Development, Alcon

  • Frederic Moll, MD, MS, Co-Founder, Intuitive, Co-Founder & Partner, Sonder Capital

  • Michelle Tarver, MD, PhD, Center Director, CDHR, FDA

Networking Break (sponsored by Ocular Therapeutix)

9:45 – 10:15 a.m.

Networking Break 
 

S3: Oculomics: Can Ocular Diagnostics with AI Improve Systemic Disease Management?

10:15 – 11:00 a.m.

​Moderators: 

  • Allen C. Ho, MD, Retina Program Director

  • Charles C. Wykoff, MD, PhD, Program Committee

​​

 

​Speakers: 

  • Carol Y. Cheung, PhD, Professor, Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong

  • Aaron Y. Lee, MD, Arthur W. Stickle Distinguished Professor and Chair, Hardesty Department of Ophthalmology and Visual Sciences, Washington University School of Medicine

  • Cecilia S. Lee, MD, MS, Professor of Ophthalmology, Washington University School of Medicine

  • David Rhew, MD, Global CMO and Vice President of Healthcare, Microsoft

  • Joel S. Schuman, MD, Professor and Vice Chair for Research Innovation, Wills Eye Hospital

  • Robert C. Sergott, MD, Executive Director, Jefferson EyeBrain Center

  • Ali Tafreshi, CEO and President, Topcon Healthcare, Inc., Founding Member, Alliance for Healthcare from the Eye

​​

​Panel: 

  • Carol Y. Cheung, PhD, Professor, Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong

  • Aaron Y. Lee, MD, Arthur W. Stickle Distinguished Professor and Chair, Hardesty Department of Ophthalmology and Visual Sciences, Washington University School of Medicine

  • Cecilia S. Lee, MD, MS, Professor of Ophthalmology, Washington University School of Medicine

  • David Rhew, MD, Global CMO and Vice President of Healthcare, Microsoft

  • Joel S. Schuman, MD, Professor and Vice Chair for Research Innovation, Wills Eye Hospital

  • Robert C. Sergott, MD, Executive Director, Jefferson EyeBrain Center

  • Ali Tafreshi, CEO and President, Topcon Healthcare, Inc., Founding Member, Alliance for Healthcare from the Eye

S4: Strategic Pathways: Driving Value Through Ophthalmic Innovation and Acquisition

11:00 – 11:45 a.m.

​Moderators: 

  • Robert L. Avery, MD, Program Co-Chair

  • Rajesh K. Rajpal, MD, Program Committee

​​​

Panel:

  • Laurent Attias, SVP Corporate Strategy, BD&L and M&A, Alcon

  • Pravin U. Dugel, MD, President & CEO, Ocular Therapeutix

  • Andrew Gitkin, Senior Managing Director, Leerink Partners

  • David R. Guyer, MD, CEO, EyeBio, A Subsidiary of Merck & Co., Inc.

  • Esther Melo, PhD, BD&L Director, Partnering, Roche Pharma

  • Peter Sandor, MD, MBA, EVP Head of Corporate Strategy, Astellas Pharma

S5: The Winning Pitch Challenge

11:45 a.m. –

12:30 p.m.

The Shark Tank-style competition will feature pitches from these three early-stage ophthalmology innovators, with judges and the audience awarding cash prizes worth $45,000. ​

​

​Finalists: 

  • Leanne Labriola, DO, MBA: InnSight Technology

  • Nikolas Pontikos, PhD: Eye2Gene Ltd

  • Joaquin Sosa-Lockward, MD: Neobuckle

​

​Moderators: 

  • Vance Thompson, MD, Ophthalmologist, Vance Thompson Vision

  • Julie M. Schallhorn, MD, MS, Professor, Ophthalmology, University of California, San Francisco   

​​​

Judges:

  • Erin Powers, MBA, President, North America, Johnson & Johnson Surgical Vision

  • Namrata Saroj, OD, Chief Business Officer, Ocular Therapeutix, Inc.

  • Firas M. Rahhal, MD, Partner, ExSight Ventures, LLC

Lunch and Networking Break

12:30 – 1:15 p.m. 

Enjoy a bite to eat with your colleagues.​​

Presenting Company Showcases

1:15 – 2:45 p.m.

Forty-two companies present innovative new treatments, products, and services. Three breakout rooms will operate simultaneously for each segment. Links for showcase schedules will be updated below:

​

Anterior Segment -  Room: W221

Moderators:

  • Julie M. Schallhorn, MD, MS, Program Committee

  • Kuldev Singh, MD, Program Committee

 

Delivery / Device / Surgical- Room: W222

Moderators:

  • Robert L. Avery, MD, Program Co-Chair

  • Rajesh K. Rajpal, MD, Program Committee

​

Posterior / Retina - Room: W230

Moderators:

  • Rishi P. Singh, MD, Incoming Chair, Department of Ophthalmology, Mass Eye and Ear, Mass General Brigham

  • Lejla Vajzovic, MD, Program Committee

Networking Break

2:45 – 3:10 p.m. 

Networking Break â€‹

Innovator Award

3:10 – 3:30 p.m. 

Presentation of Eyecelerator’s Innovator Award to Glaukos

​

​Moderator:

  • James V. Mazzo, Executive Chair, Neurotech Pharmaceuticals, Inc.

 

Panel:

​​

  • Thomas W. Burns, Chairman & CEO, Glaukos

  • Robert L. Davis, JD, SVP, General Counsel & Business Development, Glaukos

  • Joseph E. Gilliam, President & COO, Glaukos

  • Tomas Navratil, PhD, Chief Development Officer, Glaukos

  • Thomas W. Samuelson, MD, Founding Partner, Minnesota Eye Consultants

S6: Regulatory Evolution: What's New and Next at the FDA

3:30 – 4:15 p.m. 

​​Moderators:

  • Kuldev Singh, MD, Program Committee

  • Julia A. Haller, MD, Ophthalmologist-in-Chief, Wills Eye Hospital

 

Panel:

​​

  • Michelle E. Tarver, MD, PhD, Center Director, CDRH, FDA

  • Heidi I. Becker, MD, Ophthalmology Clinical Reviewer, CBER, FDA

People’s Choice Awards & Closing Bell

4:15 – 4:30 p.m. 

The program committee wraps the day with the People's Choice recognition of best presenting company by segment.  

​

Reception (sponsored by EyeBio)

4:30 – 5:15 p.m. 

Enjoy refreshments and connect!

Showcases
WPC
Park City Showcases
bottom of page